CN Patent

CN102421411A — 膀胱过动症治疗方法及奥昔布宁局部用组合物储存和施用装置

Assigned to Actavis Laboratories UT Inc · Expires 2012-04-18 · 14y expired

What this patent protects

本发明涉及一种治疗膀胱过动症的方法及一种用于储存和施用无包涵体奥昔布宁局部用组合物的装置。

USPTO Abstract

本发明涉及一种治疗膀胱过动症的方法及一种用于储存和施用无包涵体奥昔布宁局部用组合物的装置。

Drugs covered by this patent

oxybutynin-chloride (OXYBUTYNIN CHLORIDE)

Patent Metadata

Patent number: CN102421411A
Jurisdiction: CN
Classification: —
Expires: 2012-04-18
Drug substance claim: No
Drug product claim: No
Assignee: Actavis Laboratories UT Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.